AUS
NZ
UK
CA
USA
IND
Health
Which Company Holds the Edge in the Small-Cap Medical Sector: Checkpoint Therapeutics or LifeVantage?
January 15, 2025 12:03 AM PST| By Team Kalkine MediaHighlights:,Checkpoint Therapeutics,(NASDAQ:CKPT),and LifeVantage are small-cap companies in the medical sector.,LifeVantage has a lower beta of 0.82, indicating less volatility compared to Checkpoint’s beta of 1.36.,LifeVantage reports positive earn...
Talphera (NASDAQ: TLPH) Announces Key Developments in NEPHRO CRRT Clinical Study Following FDA Meeting
January 14, 2025 09:55 PM PST| By Team Kalkine MediaHighlights,FDA agrees to review PAS for reducing patient numbers in NEPHRO CRRT study.,Two protocol changes approved to accelerate enrollment, improving study efficiency.,Talphera maintains breakthrough designation status for nafamostat in CRRT.,Talp...
Analyzing Bright Health Group’s (NYSE:BHG) Recent Market Trends
January 14, 2025 09:52 AM PST| By Team Kalkine MediaHighlights,Bright Health Group shares fell 1.2% in the latest session.,Trading volume dropped 35% below the average level.,The company operates in health insurance and clinical care segments.,Bright Health Group Inc. a slight decline in stock price a...
Waters Corporation (NYSE:WAT) Stock Growth Outpaces Earnings Increase
January 14, 2025 09:42 AM PST| By Team Kalkine MediaHighlights,Waters Corporation stock has risen by 67% over the last five years.,The company achieved a compound earnings per share (EPS) growth of 5.1% annually.,Recent stock growth of 30% indicates improving performance over the past year.,Waters Cor...
Merck & Co., Inc. (NYSE:MRK) Shows Solid Performance Despite Market Trends
January 14, 2025 09:34 AM PST| By Team Kalkine MediaHighlights,Eastern Bank reduces stake in Merck & Co., Inc. by 20.3%.,Merck's stock shows stability despite market fluctuations.,Quarterly dividend increases, reflecting financial strength.,Merck & Co., Inc. continues to solidify its position in the h...
Agilon Health Inc. (NYSE:AGL) Sees Recent Stock Surge Amid Revenue Growth
January 14, 2025 09:30 AM PST| By Team Kalkine MediaHighlights,Agilon Health, Inc. sees a 29% stock price bounce in the last month.,Despite recent gains, the stock is down 61% over the past year.,The company’s P/S ratio is significantly lower than the healthcare sector average.,Agilon Health, Inc. has...
Veeva Systems (NYSE:VEEV) Adjusted Price Target Reflects Market Realities
January 14, 2025 09:00 AM PST| By Team Kalkine MediaHighlights,Veeva Systems’ stock price decreased by 2.2% recently.,The company provides cloud-based software solutions for the life sciences sector.,Truist Financial lowered Veeva's price target to $210.00.\,Veeva Systems Inc Class A has been a key pr...
What Insights Did Dr. David Feifel Share on Ketamine’s Role in Mental Health?
January 14, 2025 08:29 AM PST| By Team Kalkine MediaHighlights,HOPE Therapeutics™, Inc., a subsidiary of NRx Pharmaceuticals, focuses on innovations in medical and technological applications for neuropsychiatric care.,Dr. David Feifel, Founder of Kadima Neuropsychiatry Institute, was featured in a CNN...
SeaStar Medical (NASDAQ: ICU) Receives FDA Approval for IDE to Study SCD-ADULT in Acute Heart Failure
January 13, 2025 09:38 PM PST| By Team Kalkine MediaHighlights,FDA approval granted for feasibility study of SCD-ADULT in adult patients with acute heart failure.,$3.6 million NIH grant secured to fund the study across five clinical sites.,Breakthrough Device Designation awarded to SCD-ADULT by the FD...
BioArctic's (NASDAQ: BIOA) Partner Eisai's Leqembi SC-AI BLA Accepted by FDA, PDUFA Action Date Set
January 13, 2025 09:35 PM PST| By Team Kalkine MediaHighlights,Leqembi's subcutaneous autoinjector (SC-AI) could become the only FDA-approved at-home injectable Alzheimer's treatment.,The quick 15-second injection process simplifies administration and could reduce hospital visits.,Leqembi is already a...
Teladoc Health (NYSE: TDOC) Partners with Amazon to Expand Access to Chronic Condition Programs
January 13, 2025 08:41 PM PST| By Team Kalkine MediaHighlights,Teladoc and Amazon collaboration expands access to chronic condition programs via Amazon’s Health Benefits Connector.,Teladoc now serves over 1 million active enrollees in its diabetes, hypertension, and weight management programs.,The par...
Teva Pharmaceutical Industries Limited Overview
January 13, 2025 10:37 AM PST| By Team Kalkine MediaHeadlines,Teva Pharmaceutical Industries Limited,(NYSE:TEVA),remains a prominent entity in the pharmaceutical sector, with recent updates highlighting shifts in ownership and ongoing evaluations by brokerages. The company has garnered attention due t...
Danaher Co. (NYSE:DHR) Sees Decline Amid Strong Quarterly Growth
January 13, 2025 08:45 AM PST| By Team Kalkine MediaHighlights,Harbor Capital Advisors reduces its stake in Danaher by 38.4%.,Danaher’s stock has been experiencing a slight decline, down 1.3%.,The company’s quarterly revenue increased by 3.1% year-over-year.,Danaher Corporation recently made an import...
Analyzing InspireMD's Stock Trend and Performance (NASDAQ:NSPR)
January 13, 2025 08:17 AM PST| By Team Kalkine MediaHighlights,InspireMD’s stock opened at $2.76, reflecting recent market trends.,Hedge fund Parkman Healthcare Partners acquired 104,081 shares in the company.,Focus on medical devices for vascular diseases.,In recent developments, the stock of Inspire...
How Will Walgreens Navigate Its Recent Losses and Mounting Challenges?
January 13, 2025 01:26 AM PST| By Team Kalkine MediaHighlights:,Walgreens,(NASDAQ:WBA),has experienced a significant decline in stock value, impacted by competition from large retail companies.,Cost-cutting measures, including store closures and a restructuring program, are being implemented to addres...
What Key Developments Are Shaping Telix Pharmaceuticals' Future Success?
January 13, 2025 01:18 AM PST| By Team Kalkine MediaHighlights:,Telix Pharmaceuticals reported strong Q4 2024 performance with significant revenue growth year-over-year and quarter-over-quarter.,Key developments include the submission of a Biologics License Application for renal cancer imaging and FDA...
What Does Amarin’s Latest Stock Movement Say About Its Future?
January 13, 2025 01:09 AM PST| By Team Kalkine MediaHighlights:,Amarin Corporation is a pharmaceutical company with a market capitalization of $226.61 million.,The stock shows a negative price-to-earnings ratio of -6.13.,The stock price has ranged between a twelve-month low of $0.43 and a high of $1.3...
How Does Mirum Pharmaceuticals Attract Talent with Stock Options and RSUs?
January 13, 2025 12:34 AM PST| By Team Kalkine MediaHighlights,Mirum Pharmaceuticals,(NASDAQ:MIRM),grants inducement awards to new employees.,The awards consist of stock options and restricted stock units (RSUs).,Stock options have an exercise price of $41.32, with a four-year vesting schedule.,The bi...
Telix Pharmaceuticals (Nasdaq: TLX) Acquires Next-Generation Therapeutic Pipeline and Biologics Platform from ImaginAb
January 12, 2025 08:48 PM PST| By Team Kalkine MediaHighlights,Telix Pharmaceuticals expands its pipeline with next-gen therapeutic candidates targeting DLL31 and integrin αvβ6.,Acquisition includes a state-of-the-art California research facility and advanced antibody engineering technology.,Strategic...
Invivyd (NASDAQ: IVVD) Announces Continued Effectiveness of PEMGARDA™ Against SARS-CoV-2 Variant XEC
January 10, 2025 05:05 AM PST| By Team Kalkine MediaHighlights,PEMGARDA™ shows sustained neutralizing activity against the XEC variant, covering 69% of U.S. variants.,The drug has demonstrated effectiveness against over 75% of circulating U.S. variants, surpassing previous medicines.,PEMGARDA™ maintai...
